Please assess the completion status of the following clinical trial:

Trial Title: A Study to Test Different Doses of BI 456906 in Patients With Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients ≥ 18 years and \< 70 years of age at screening~* Body Mass Index (BMI) ≥ 27 kg/m2 and \<40 kg/m2 at screening~* A minimum absolute body weight of 70 kg at screening and a stable body weight (defined as no more than 5% change) 3 months prior to screening~* HbA1c \<6.5%~* Further inclusion criteria apply~Exclusion Criteria:~* Women who are pregnant, nursing, or who plan to become pregnant while in the trial~* Supine blood pressure (BP) ≥160/100 mmHg at screening~* Major surgery (major according to the investigator's assessment) performed within 12 weeks prior to randomization or planned within 12 months after screening~* Any laboratory value outside the reference range that the investigator considers to be of clinical relevance~* Further exclusion criteria apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- BI 456906 (Type: EXPERIMENTAL): None
- Placebo (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).